This phase I trial using PSA-TRICOM with Ipilimumab (Ipi) showed promise for Overall Survival (OS).
On June 5, 2012, Tricom announced their intent to begin a buildout of a Hybrid fibre-coaxial network across Bayahibe, Bonao, Casa de Campo, La Romana, La Vega, San Cristóbal, San Francisco de Macorís, San Pedro de Macorís, Santiago, and Santo Domingo.